Call the Pradaxa Helpline Louisiana and speak to a geriatric social worker and Pradaxa Lawyer regarding the Pradaxa lawsuits. Pradaxa helpline for the residents of Lousiana who have lost a loved one or have had serious extensive, life threatening bleeding from pradaxa
Pradaxa helpline for the residents of Lousiana who have lost a loved one or have had serious extensive, life threatening bleeding from pradaxa.
- New Orleans, LA
- Baton Rouge,
- Lake Charles, LA
- Bossier City,
- New Iberia,
On May 4, researchers at the 2012 Thrombosis and Hemotasis Summit of North America in Chicago announced early data from a study which examined the health risks of alternative blood thinners. The review, sponsored by Alere Inc., found doctors removing patients from Pradaxa earlier and more often than Coumadin (warfarin) due to complications during treatment.
Side effects of Pradaxa® include:
- bleeding that lasts a long time and/or can't be stopped
- unexpected bleeding
- bleeding that is out of control
- bruises that appear without cause
- bruising more easily
- frequent and unexplained nose bleeds
- heavier-than-normal menstrual bleeding
- coughing up blood clots
- dizziness, headaches
- vomiting blood
- vomit that looks like coffee grounds
- pink or brown urine, red or black stools
- unexpected pain, swelling, or joint pain
Louisiana pradaxa Breaking News
Pradaxa Lawsuit Filed for Internal Bleeding, Pradaxa helpline Concerned for seniors and Internal beleeding from Pradaxa
A couple in Lafayette, Louisiana reportedly filed a Pradaxa lawsuit earlier this month for serious bleeding problems and the subsequent need for surgery.
According to reports, Garland Lege and his wife Patricia filed a lawsuit March 5 against Boehringer Ingelheim. The pharmaceutical company makes Pradaxa which has been criticized for causing internal bleeding.
The couple, reportedly, claims that after taking the heart medication Pradaxa®, Mr. Lege endured internal bleeding of the gastrointestinal tract. He needed to be hospitalized for two weeks for the bleeding problem. Then, to control the bleeding, doctors had to perform numerous medical procedures on the patient. This included an operation to remove part of his colon.
The lawsuit says that Boehringer failed to sufficiently warn healthcare professionals as well as consumers about the bleeding dangers linked to Pradaxa®. The suit also claims that the drug company did not adequately tell doctors how to stabilize patients once they began uncontrollable internal bleeding.
The defendants in the lawsuit are Boehringer Ingelheim Pharmaceuticals Inc, Boehringer Ingelheim Pharma GmbH & Co KG, Boehringer Ingelheim International GmbH, and Bidachem S.p.A.
The Leges demanded a jury trial. The case will be heard in the Louisiana Western District Court, Lafayette County.
Pradaxa® is an anticoagulant medication. It is prescribed to keep blood from clotting and prevent heart attacks and strokes. In January, the Archives of Internal Medicine published an article saying a recent study showed patients had a higher risk of heart attack on Pradaxa® than patients on the competing drug Warfarin or patients taking a placebo.
Pradaxa® received U.S. Food and Drug (FDA) approval in October 2010. About 15 months later, in December 2012, the U.S. FDA issued a safety alert about the drug’s potential to cause serious internal bleeding.